Stroke prevention as an indication for the Maze procedure in the treatment of atrial fibrillation (Q73622849)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10746924%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Stroke prevention as an indication for the Maze procedure in the treatment of atrial fibrillation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10746924%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

N Ad

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10746924%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J L Cox

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10746924%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10746924%20AND%20SRC:MED&resulttype=core&format=json

Seminars in thoracic and cardiovascular surgery

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10746924%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10746924%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10746924%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

56-62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10746924%20AND%20SRC:MED&resulttype=core&format=json

Coronary heart disease and atrial fibrillation: the Framingham Study

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2800%2970018-9

7 January 2021

Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2800%2970018-9

7 January 2021

Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2800%2970018-9

7 January 2021

Rate issues in atrial fibrillation: consequences of tachycardia and therapy for rate control

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2800%2970018-9

7 January 2021

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2800%2970018-9

7 January 2021

Impact of atrial fibrillation on mortality, stroke, and medical costs

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2800%2970018-9

7 January 2021

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2800%2970018-9

7 January 2021

Prevention of stroke in patients with nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2800%2970018-9

7 January 2021

Recent national patterns of warfarin use in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2800%2970018-9

7 January 2021

Warfarin use among patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2800%2970018-9

7 January 2021

Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2800%2970018-9

7 January 2021

Epidemiologic features of asymptomatic cerebral infarction in patients with nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2800%2970018-9

7 January 2021

Silent cerebral infarction in chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2800%2970018-9

7 January 2021

Epidemiologic features of chronic atrial fibrillation: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2800%2970018-9

7 January 2021

Successful surgical treatment of atrial fibrillation. Review and clinical update

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2800%2970018-9

7 January 2021

Modification of the maze procedure for atrial flutter and atrial fibrillation. I. Rationale and surgical results

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2800%2970018-9

7 January 2021

Modification of the maze procedure for atrial flutter and atrial fibrillation. II. Surgical technique of the maze III procedure

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2800%2970018-9

7 January 2021

Five-year experience with the maze procedure for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2800%2970018-9

7 January 2021

An 8 1/2-year clinical experience with surgery for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2800%2970018-9

7 January 2021

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2800%2970018-9

7 January 2021

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2800%2970018-9

7 January 2021

Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2800%2970018-9

7 January 2021

Canadian atrial fibrillation anticoaguiation (CAFA) study

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2800%2970018-9

7 January 2021

Stroke Prevention in Atrial Fibrillation Study. Final results

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2800%2970018-9

7 January 2021

Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2800%2970018-9

7 January 2021

Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2800%2970018-9

7 January 2021

Impact of the maze procedure on the stroke rate in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2800%2970018-9

7 January 2021

10.1016/S1043-0679(00)70018-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10746924%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference